Michelangelo Russillo

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

Violeta Serra, Maurizio Scaltriti, Ludmila Prudkin et al. · Oncogene · 2011 · 534 citations · Full text

Medicine, Cancer Biology, Pharmacology +17

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

Giulio Metro, Jennifer Foglietta, Michelangelo Russillo et al. · Annals of Oncology · 2010 · 168 citations

Medicine, Oncology, Breast Oncology +15

Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center

Alessandra Fabi, Alessandra Felici, Giulio Metro et al. · Journal of Experimental & Clinical Cancer Research · 2011 · 122 citations · Full text

Medicine, Radiation Oncology, Surgery +14

Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials

Valentina Rossi, Paola Berchialla, Diana Giannarelli et al. · Cancers · 2019 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer

Alessandra Fabi, Daniele Alesini, Enrichetta Valle et al. · The Breast · 2018 · 58 citations

Medicine, Neurology, Oncology +16